Primary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type called cholangiocarcinoma (CCA). This cancer is ...
Jun 20, 2024
0
0
Gastrointestinal (GI) cancers, encompassing esophageal, gastric, small bowel, and colorectal carcinomas, represent a significant global health burden due to their high incidence and mortality rates. A review by M. Jesús ...
Jun 18, 2024
0
0
Focusing on four common diseases—diabetes, heart disease, depression and bowel cancer—new Flinders University research provides insights into the importance of a healthy microbiome balance in the human gut and in the ...
Jun 17, 2024
0
0
A medication used for psoriasis and psoriatic arthritis is proving to be an effective treatment for moderate to severe ulcerative colitis in the findings of a global study led by University of Chicago Medicine's David T. ...
Jun 17, 2024
0
1
Microbiome research to date has been much like the parable of the blind men and the elephant. How much can be said about an elephant by examining just its tail? Researchers have studied what is most readily available—stool ...
Jun 17, 2024
0
1
No, you're not imagining it. People really are more likely to poo in the morning, shortly after breakfast. Researchers have actually studied this.
Jun 17, 2024
0
1
Results from a new trial indicate that immunotherapy could successfully be used to treat the most common form of colorectal cancer, also known as bowel cancer.
Jun 14, 2024
0
32
The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among patients undergoing colonoscopy, according to a study published in the ...
Jun 13, 2024
0
0
Researchers at the University of Kentucky have found that, for much of the past two decades, Appalachian Kentuckians have been more likely to die from colorectal cancer compared to the rest of the state and country's population.
Jun 13, 2024
0
0
Developing chemotherapy drugs against breast cancer is costly, slow, and often inefficient, with more than 95% of screened drug candidates failing in patient trials. A new technique for 3D cell culturing, developed by researchers ...
Jun 11, 2024
0
1
